Internationalization of preparations is the only way for the transformation of Chinese Pharmaceutical Enterprises

Some people said: if the cost and scale advantages of APIs are lost, and trust cannot be built in Europe and the United States, the advantages of Chinese api enterprises will be nothing Therefore, with the gradual decline of price advantage, API enterprises need to find a new way to catch up with other enterprises through the internationalization of preparations Related enterprises can make the following efforts in the internationalization of preparations One is the promotion of ideas On the one hand, the factory adopts high standard design, which meets the requirements of GMP double certification at home and abroad; on the other hand, it constructs the concept of green development Second, chemical manufacturing Not only build their own API platform, but also commit to the development of preparations Third, the choice of varieties The API should select environmentally friendly and technically difficult varieties; the preparation should meet the standards of European and American people to take medicine and strive to be an industrial chain The key point for Chinese pharmaceutical companies to formulate their internationalization strategy is to develop generic preparations with specificity as the core competitiveness; to take into account the development of preparations in both domestic and international markets; to consolidate the domestic market; to strengthen international cooperation and to establish a comprehensive talent team with transnational management experience and high quality Based on the analysis of the fundamentals of domestic pharmaceutical enterprises, although for domestic pharmaceutical enterprises, transformation and upgrading, and going out of the face of multiple pressures, this is the way the industry must go